Antenatal predictors of incident and persistent postnatal depressive symptoms in rural Ethiopia: a population-based prospective study.
Depressive symptoms
Ethiopia
Incidence
Low and middle income countries
Perinatal depression
Persistent depression
Postnatal depression
Journal
Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380
Informations de publication
Date de publication:
04 Mar 2019
04 Mar 2019
Historique:
received:
07
12
2018
accepted:
19
02
2019
entrez:
6
3
2019
pubmed:
6
3
2019
medline:
16
3
2019
Statut:
epublish
Résumé
There have been few studies to examine antenatal predictors of incident postnatal depression, particularly in low- and middle-income countries (LMICs). The aim of this study was to investigate antenatal predictors of incident and persistent maternal depression in a rural Ethiopian community in order to inform development of antenatal interventions. A population-based prospective study was conducted in Sodo district, south central Ethiopia. A locally validated version of the Patient Health Questionnaire (PHQ-9) was used to assess antenatal (second and third trimesters) and postnatal (4-12 weeks after childbirth) depressive symptoms, with a PHQ-9 cut-off of five or more indicating high depressive symptoms. Poisson regression with robust standard errors was used to identify independent predictors of persistence and incidence of postnatal depressive symptoms from a range of antenatal, clinical and psychosocial risk factors. Out of 1311 women recruited antenatally, 1240 (356 with and 884 without antenatal depressive symptoms) were followed up in the postnatal period. Among 356 women with antenatal depressive symptoms, the elevated symptoms persisted into postnatal period in 138 women (38.8%). Out of 884 women without antenatal depressive symptoms, 136 (15.4%) experienced incident elevated depressive symptoms postnatally. The prevalence of high postnatal depressive symptoms in the follow-up sample was 274 (22.1%). Higher intimate partner violence scores in pregnancy were significantly associated with greater risk of incident depressive symptoms [adjusted Risk Ratio (aRR) = 1.06, 95% CI: 1.00, 1.12]. Each 1-point increment in baseline PHQ-9 score predicted an increased risk of incidence of postnatal depressive symptoms (aRR = 1.29, 95% CI: 1.15, 1.45). There was no association between self-reported pregnancy complications, medical conditions or experience of threatening life events with either incidence or persistence of depressive symptoms. Psychological and social interventions to address intimate partner violence during pregnancy may be the most important priorities, able to address both incident and persistent depression.
Sections du résumé
BACKGROUND
BACKGROUND
There have been few studies to examine antenatal predictors of incident postnatal depression, particularly in low- and middle-income countries (LMICs). The aim of this study was to investigate antenatal predictors of incident and persistent maternal depression in a rural Ethiopian community in order to inform development of antenatal interventions.
METHOD
METHODS
A population-based prospective study was conducted in Sodo district, south central Ethiopia. A locally validated version of the Patient Health Questionnaire (PHQ-9) was used to assess antenatal (second and third trimesters) and postnatal (4-12 weeks after childbirth) depressive symptoms, with a PHQ-9 cut-off of five or more indicating high depressive symptoms. Poisson regression with robust standard errors was used to identify independent predictors of persistence and incidence of postnatal depressive symptoms from a range of antenatal, clinical and psychosocial risk factors.
RESULT
RESULTS
Out of 1311 women recruited antenatally, 1240 (356 with and 884 without antenatal depressive symptoms) were followed up in the postnatal period. Among 356 women with antenatal depressive symptoms, the elevated symptoms persisted into postnatal period in 138 women (38.8%). Out of 884 women without antenatal depressive symptoms, 136 (15.4%) experienced incident elevated depressive symptoms postnatally. The prevalence of high postnatal depressive symptoms in the follow-up sample was 274 (22.1%). Higher intimate partner violence scores in pregnancy were significantly associated with greater risk of incident depressive symptoms [adjusted Risk Ratio (aRR) = 1.06, 95% CI: 1.00, 1.12]. Each 1-point increment in baseline PHQ-9 score predicted an increased risk of incidence of postnatal depressive symptoms (aRR = 1.29, 95% CI: 1.15, 1.45). There was no association between self-reported pregnancy complications, medical conditions or experience of threatening life events with either incidence or persistence of depressive symptoms.
CONCLUSION
CONCLUSIONS
Psychological and social interventions to address intimate partner violence during pregnancy may be the most important priorities, able to address both incident and persistent depression.
Identifiants
pubmed: 30832700
doi: 10.1186/s12978-019-0690-0
pii: 10.1186/s12978-019-0690-0
pmc: PMC6399829
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
28Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M025470/1
Pays : United Kingdom
Organisme : AID from the UK government as part of initiative of the Programme for Improving Mental Health Care (PRIME)
ID : PO 5248
Références
Obstet Gynecol. 2000 Apr;95(4):487-90
pubmed: 10725477
J Qual Clin Pract. 2001 Dec;21(4):144-8
pubmed: 11856412
J Psychosom Res. 2002 Oct;53(4):897-902
pubmed: 12377300
Am J Epidemiol. 2002 Nov 1;156(9):797-802
pubmed: 12396996
Obstet Gynecol. 2004 Apr;103(4):698-709
pubmed: 15051562
Arch Gen Psychiatry. 2004 Sep;61(9):946-52
pubmed: 15351773
Eur J Epidemiol. 2004;19(8):751-60
pubmed: 15469032
Ann Fam Med. 2004 Nov-Dec;2(6):555-62
pubmed: 15576541
Can J Psychiatry. 2004 Nov;49(11):726-35
pubmed: 15633850
Acta Obstet Gynecol Scand. 2006;85(8):937-44
pubmed: 16862471
Br J Psychiatry. 2006 Sep;189:241-6
pubmed: 16946359
J Egypt Public Health Assoc. 1994;69(5-6):397-424
pubmed: 17212007
Acta Psychiatr Scand. 2007 Jun;115(6):481-6
pubmed: 17498160
BMC Public Health. 2007 Aug 16;7:209
pubmed: 17705835
BMC Womens Health. 2007 Sep 27;7:15
pubmed: 17900360
Epidemiology. 2007 Nov;18(6):800-4
pubmed: 18049194
J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6
pubmed: 18301133
Arch Dis Child. 2008 Jun;93(6):458-61
pubmed: 18495909
JNMA J Nepal Med Assoc. 2008 Jul-Sep;47(171):128-31
pubmed: 19079377
Trop Med Int Health. 2009 Feb;14(2):156-66
pubmed: 19187514
Am J Obstet Gynecol. 2010 Jan;202(1):5-14
pubmed: 20096252
BMC Psychiatry. 2010 Apr 30;10:32
pubmed: 20433695
Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F59-64
pubmed: 20667895
Arch Gen Psychiatry. 2010 Oct;67(10):1012-24
pubmed: 20921117
Br J Psychiatry. 2010 Dec;197(6):468-75
pubmed: 21119153
Dialogues Clin Neurosci. 2011;13(1):7-23
pubmed: 21485743
Reprod Health. 2011 May 02;8:9
pubmed: 21535876
Arch Womens Ment Health. 2011 Oct;14(5):395-403
pubmed: 21898171
BMC Public Health. 2011 Oct 26;11:828
pubmed: 22029430
CMAJ. 2012 Feb 21;184(3):E191-6
pubmed: 22184363
J Affect Disord. 2012 Feb;136(3):340-9
pubmed: 22196052
J Obstet Gynaecol. 2012 Apr;32(3):237-40
pubmed: 22369395
Bull World Health Organ. 2012 Feb 1;90(2):139G-149G
pubmed: 22423165
BMC Psychiatry. 2012 Mar 22;12:22
pubmed: 22436053
PLoS One. 2012;7(8):e43462
pubmed: 22937052
BMC Psychiatry. 2012 Sep 19;12:148
pubmed: 22989114
Fam Med. 1990 Jan-Feb;22(1):25-8
pubmed: 2303178
PLoS One. 2012;7(10):e48396
pubmed: 23110236
Psychiatry Res. 2013 Dec 15;210(2):653-61
pubmed: 23972787
Acta Psychiatr Scand. 1990 Jul;82(1):77-81
pubmed: 2399824
BMC Med. 2014 Jan 28;12:14
pubmed: 24472627
J Affect Disord. 2014 Jun;162:1-7
pubmed: 24766996
BMC Psychiatry. 2014 Jul 07;14:194
pubmed: 24999041
Early Interv Psychiatry. 2017 Feb;11(1):57-62
pubmed: 25582677
J Affect Disord. 2015 Apr 1;175:385-95
pubmed: 25678171
Psychol Med. 2015 Jul;45(9):1999-2012
pubmed: 25678201
Int J Obes (Lond). 2015 Dec;39(12):1710-6
pubmed: 26095247
Paediatr Perinat Epidemiol. 2015 Nov;29(6):505-14
pubmed: 26236987
J Affect Disord. 2016 Mar 1;192:70-5
pubmed: 26707350
Seishin Shinkeigaku Zasshi. 2015;117(11):902-9
pubmed: 26901890
Psychol Health Med. 2017 Jan;22(1):65-74
pubmed: 26920489
J Affect Disord. 2016 Oct;203:121-129
pubmed: 27285725
Nutr J. 2016 Jul 11;15(1):64
pubmed: 27401187
BMC Pregnancy Childbirth. 2016 Oct 10;16(1):301
pubmed: 27724876
Noro Psikiyatr Ars. 2015 Dec;52(4):359-366
pubmed: 28360740
J Affect Disord. 2017 Sep;219:86-92
pubmed: 28531848
J Affect Disord. 2017 Dec 1;223:194-208
pubmed: 28763638
BMC Psychiatry. 2017 Aug 22;17(1):301
pubmed: 28830395
Ann N Y Acad Sci. 1994 Oct 31;739:198-210
pubmed: 7832474
Eur J Epidemiol. 1995 Aug;11(4):365-71
pubmed: 8549701
Fam Med. 1996 Jun;28(6):422-8
pubmed: 8791071
Ann Intern Med. 1998 Aug 1;129(3):229-40
pubmed: 9696732